Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Gaëlle Clavel, Marie-Christophe Boissier, Johanna Sigaux & Luca Semerano. (2017) Developments with experimental and investigational drugs for axial spondyloarthritis. Expert Opinion on Investigational Drugs 26:7, pages 833-842.
Read now
Read now
Gita Gelfer, Lisa Perry & Atul Deodhar. (2016) Golimumab for the treatment of axial spondyloarthritis. Expert Review of Clinical Immunology 12:1, pages 9-18.
Read now
Read now
Daniel Wendling. (2016) An overview of investigational new drugs for treating ankylosing spondylitis. Expert Opinion on Investigational Drugs 25:1, pages 95-104.
Read now
Read now
Carlo Palazzi, Salvatore D’Angelo, Michele Gilio, Pietro Leccese, Angela Padula & Ignazio Olivieri. (2015) Pharmacological therapy of spondyloarthritis. Expert Opinion on Pharmacotherapy 16:10, pages 1495-1504.
Read now
Read now
Juergen Braun, Uta Kiltz, Frank Heldmann & Xenofon Baraliakos. (2015) Emerging drugs for the treatment of axial and peripheral spondyloarthritis. Expert Opinion on Emerging Drugs 20:1, pages 1-14.
Read now
Read now
Articles from other publishers (13)
Aliki I. Venetsanopoulou, Konstantina Mavridou, Paraskevi V. Voulgari & Alexandros A. Drosos. (2023) Cutaneous immune-related phenomena in patients with inflammatory arthritides treated with biological therapies: Clinical and pathophysiological considerations. Seminars in Arthritis and Rheumatism 63, pages 152272.
Crossref
Crossref
Jonathan Kennedy, Natasha Kennedy, Roxanne Cooksey, Ernest Choy, Stefan Siebert, Muhammad Rahman & Sinead Brophy. (2023) Predicting a diagnosis of ankylosing spondylitis using primary care health records–A machine learning approach. PLOS ONE 18:3, pages e0279076.
Crossref
Crossref
Rouhin Sen & Liron Caplan. (2022) Current treatment and molecular targets for axial spondyloarthritis: Evidence from randomized controlled trials. Current Opinion in Pharmacology 67, pages 102307.
Crossref
Crossref
Georg Schett, Xenofon Baraliakos, Filip Van den Bosch, Atul Deodhar, Mikkel Østergaard, Ayan Das Gupta, Shephard Mpofu, Todd Fox, Adam Winseck, Brian Porter, Abhijit Shete & Lianne S. Gensler. (2021) Secukinumab Efficacy on Enthesitis in Patients With Ankylosing Spondylitis: Pooled Analysis of Four Pivotal Phase III Studies. The Journal of Rheumatology 48:8, pages 1251-1258.
Crossref
Crossref
James Cheng-Chung Wei, Wen-Chan Tsai, Gustavo Citera, Sameer Kotak & Lyndon Llamado. (2018) Efficacy and safety of etanercept in patients from Latin America, Central Europe and Asia with early non-radiographic axial spondyloarthritis. International Journal of Rheumatic Diseases 21:7, pages 1443-1451.
Crossref
Crossref
Marlies J. G. Carbo, Anneke Spoorenberg, Fiona Maas, Elisabeth Brouwer, Reinhard Bos, Hendrika Bootsma, Eveline van der Veer, Freke Wink & Suzanne Arends. (2018) Ankylosing spondylitis disease activity score is related to NSAID use, especially in patients treated with TNF-α inhibitors. PLOS ONE 13:4, pages e0196281.
Crossref
Crossref
Atul Deodhar & David Yu. (2017) Switching tumor necrosis factor inhibitors in the treatment of axial spondyloarthritis. Seminars in Arthritis and Rheumatism 47:3, pages 343-350.
Crossref
Crossref
Vidya Ranganathan, Francesco Ciccia, Fanxing Zeng, Ismail Sari, Guiliana Guggino, Janogini Muralitharan, Eric Gracey & Nigil Haroon. (2017) Macrophage Migration Inhibitory Factor Induces Inflammation and Predicts Spinal Progression in Ankylosing Spondylitis. Arthritis & Rheumatology 69:9, pages 1796-1806.
Crossref
Crossref
Bente Glintborg, Inge J. Sørensen, Mikkel Østergaard, Lene Dreyer, Abdiweli A. Mohamoud, Niels S. Krogh, Oliver Hendricks, Lis S. Andersen, Johnny L. Raun, Marcin R. Kowalski, Laura Danielsen, Randi Pelck, Henrik Nordin, Jens K. Pedersen, Dorte G.A. Kraus, Susan R. Christensen, Inger M.J. Hansen, Jakob Esbesen, Annette Schlemmer, Anne G. Loft, Nabil al Chaer, Lone Salomonsen & Merete L. Hetland. (2017) Ankylosing Spondylitis versus Nonradiographic Axial Spondyloarthritis: Comparison of Tumor Necrosis Factor Inhibitor Effectiveness and Effect of HLA-B27 Status. An Observational Cohort Study from the Nationwide DANBIO Registry. The Journal of Rheumatology 44:1, pages 59-69.
Crossref
Crossref
Klára Prajzlerová, Kristýna Grobelná, Karel Pavelka, Ladislav Šenolt & Mária Filková. (2016) An update on biomarkers in axial spondyloarthritis. Autoimmunity Reviews 15:6, pages 501-509.
Crossref
Crossref
Bente Glintborg, Pil Højgaard, Merete Lund Hetland, Niels Steen Krogh, Gina Kollerup, Jørgen Jensen, Stavros Chrysidis, Inger Marie Jensen Hansen, Mette Holland-Fischer, Torben Højland Hansen, Christine Nilsson, Jakob Espesen, Henrik Nordin, Anne Gitte Rasmussen Loft, Randi Pelck, Tove Lorenzen, Sussi Flejsborg Oeftiger, Barbara Unger, Frank Jaeger, Peter Mosborg Petersen, Claus Rasmussen & Lene Dreyer. (2016) Impact of tobacco smoking on response to tumour necrosis factor-alpha inhibitor treatment in patients with ankylosing spondylitis: results from the Danish nationwide DANBIO registry. Rheumatology 55:4, pages 659-668.
Crossref
Crossref
Chao Chen, XiaoLin Zhang, Lu Xiao, XueSong Zhang & XinLong Ma. (2016) Comparative Effectiveness of Biologic Therapy Regimens for Ankylosing Spondylitis. Medicine 95:11, pages e3060.
Crossref
Crossref
Ewa Kontny. (2014) New aspects of spondyloarthritis pathogenesis. Part III – arthritis, pathological bone remodeling. Rheumatology 52:4, pages 247-254.
Crossref
Crossref